13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0000905148-25-004034
Total Value
$176.4M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PHARVARIS N V | PHVS | 4,639,304 | $115.8M | 65.62% |
| 2 | ALUMIS INC | ALMS | 4,619,803 | $18.4M | 10.45% |
| 3 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $17.8M | 10.06% |
| 4 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 489,194 | $13.5M | 7.64% |
| 5 | LYELL IMMUNOPHARMA INC | LYEL | 473,479 | $7.7M | 4.36% |
| 6 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 1,148,975 | $3.3M | 1.87% |